Cargando…
Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: firs...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548402/ https://www.ncbi.nlm.nih.gov/pubmed/34702829 http://dx.doi.org/10.1038/s41467-021-26452-z |
_version_ | 1784590565315182592 |
---|---|
author | Bottomley, C. Otiende, M. Uyoga, S. Gallagher, K. Kagucia, E. W. Etyang, A. O. Mugo, D. Gitonga, J. Karanja, H. Nyagwange, J. Adetifa, I. M. O. Agweyu, A. Nokes, D. J. Warimwe, G. M. Scott, J. A. G. |
author_facet | Bottomley, C. Otiende, M. Uyoga, S. Gallagher, K. Kagucia, E. W. Etyang, A. O. Mugo, D. Gitonga, J. Karanja, H. Nyagwange, J. Adetifa, I. M. O. Agweyu, A. Nokes, D. J. Warimwe, G. M. Scott, J. A. G. |
author_sort | Bottomley, C. |
collection | PubMed |
description | As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: first the proportion above a threshold antibody level is calculated, then the crude estimate is adjusted using external estimates of sensitivity and specificity. A drawback of this approach is that the PCR-confirmed cases used to estimate the sensitivity of the threshold may not be representative of cases in the wider population—e.g., they may be more recently infected and more severely symptomatic. Mixture modelling offers an alternative approach that does not require external data from PCR-confirmed cases. Here we illustrate the bias in the standard threshold-based approach by comparing both approaches using data from several Kenyan serosurveys. We show that the mixture model analysis produces estimates of previous infection that are often substantially higher than the standard threshold analysis. |
format | Online Article Text |
id | pubmed-8548402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85484022021-10-29 Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels Bottomley, C. Otiende, M. Uyoga, S. Gallagher, K. Kagucia, E. W. Etyang, A. O. Mugo, D. Gitonga, J. Karanja, H. Nyagwange, J. Adetifa, I. M. O. Agweyu, A. Nokes, D. J. Warimwe, G. M. Scott, J. A. G. Nat Commun Article As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: first the proportion above a threshold antibody level is calculated, then the crude estimate is adjusted using external estimates of sensitivity and specificity. A drawback of this approach is that the PCR-confirmed cases used to estimate the sensitivity of the threshold may not be representative of cases in the wider population—e.g., they may be more recently infected and more severely symptomatic. Mixture modelling offers an alternative approach that does not require external data from PCR-confirmed cases. Here we illustrate the bias in the standard threshold-based approach by comparing both approaches using data from several Kenyan serosurveys. We show that the mixture model analysis produces estimates of previous infection that are often substantially higher than the standard threshold analysis. Nature Publishing Group UK 2021-10-26 /pmc/articles/PMC8548402/ /pubmed/34702829 http://dx.doi.org/10.1038/s41467-021-26452-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Bottomley, C. Otiende, M. Uyoga, S. Gallagher, K. Kagucia, E. W. Etyang, A. O. Mugo, D. Gitonga, J. Karanja, H. Nyagwange, J. Adetifa, I. M. O. Agweyu, A. Nokes, D. J. Warimwe, G. M. Scott, J. A. G. Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels |
title | Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels |
title_full | Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels |
title_fullStr | Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels |
title_full_unstemmed | Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels |
title_short | Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels |
title_sort | quantifying previous sars-cov-2 infection through mixture modelling of antibody levels |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548402/ https://www.ncbi.nlm.nih.gov/pubmed/34702829 http://dx.doi.org/10.1038/s41467-021-26452-z |
work_keys_str_mv | AT bottomleyc quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT otiendem quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT uyogas quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT gallagherk quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT kaguciaew quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT etyangao quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT mugod quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT gitongaj quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT karanjah quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT nyagwangej quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT adetifaimo quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT agweyua quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT nokesdj quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT warimwegm quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels AT scottjag quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels |